| Impairing MLL-fusion gene mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75). | |
| | |
MedLine Citation:
|
PMID: 23318960 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The lens epithelium-derived growth factor (LEDGF/p75) tethers the mixed lineage leukemia (MLL1) protein complex to chromatin. Likewise, LEDGF/p75 tethers the human immunodeficiency virus 1 (HIV-1) pre-integration complex to chromatin. We previously demonstrated that expression of the C-terminal fragment fused to eGFP (eGFP-LEDGF(325-530)) impaired HIV-1 replication. Here, we explored this strategy to selectively interfere with the leukemogenic activity of MLL-fusion proteins. We found that expression of LEDGF(325-530) impaired the clonogenic growth of MLL-fusion gene transformed human and mouse hematopoietic cells, without affecting the growth of control cells immortalized by the FLT3-ITD mutant or normal lineage marker-depleted murine bone marrow cells. Expression of LEDGF(325-530) was associated with downregulation of the MLL target Hoxa9 and impaired cell cycle progression. Structure-function analysis revealed two small eGFP fused LEDGF/p75 peptides, LEDGF(424-435) and LEDGF(375-386) phenocopying these effects. Both LEDGF(325-530) and the smaller active peptides were able to disrupt the LEDGF/p75-MLL interaction. Expression of LEDGF(325-530) or LEDGF(375-386) fragments increased the latency period to disease development in vivo in a mouse bone marrow transplant model of MLL-AF9 induced AML. We conclude that small peptides disrupting the LEDGF/p75-MLL interface have selective anti-leukemic activity providing a direct rationale for the design of small molecule inhibitors targeting this interaction.Leukemia accepted article preview online, 15 January 2013; doi:10.1038/leu.2013.10. |
| | |
Authors:
|
H Méreau; J De Rijck; K Cermáková; A Kutz; S Juge; J Demeulemeester; R Gijsbers; F Christ; Z Debyser; J Schwaller |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-15 |
Journal Detail:
|
Title: Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K Volume: - ISSN: 1476-5551 ISO Abbreviation: Leukemia Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8704895 Medline TA: Leukemia Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Biomedicine, University Hospital & Children's Hospital (UKBB), KU Leuven, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic acti...
Next Document: Bilirubin clearance and antioxidant activities of ethanol extract of Phyllanthus amarus root in phen...